ORGANIC
LETTERS
2013
Vol. 15, No. 1
62–64
Stereoselective Synthesis of the
Disaccharide Unit of Incednine
Jason R. Abbott and William R. Roush*
Department of Chemistry, The Scripps Research Institute;Florida,
130 Scripps Way Jupiter, Florida 33458, United States
Received November 9, 2012
ABSTRACT
A stereoselective synthesis of a fully protected version of the disaccharide unit (2) of incednine (1) is described. The synthesis of 2 proceeds in
4.7% overall yield from commercially available allyl R-D-galactopyranoside over the longest linear sequence.
The structure determination of incednine (1), isolated
from Streptomyces sp. ML694-90F3 using a cell-based
chemical-genetic screen targeting inhibitors of the onco-
protein Bcl-xL, was reported in 2008.1 It was reported in
this initial publication that incednine induced apoptosis in
Bcl-xL-overexpressing cells, thereby sensitizing these other-
wise resistant cells to chemotherapeutic treatment. Unlike
most existing Bcl-xL inhibitors, which recognize surface
binding pockets on this protein, incednine neither dis-
rupted the binding of Bcl-xL to the pro-apoptotic Bcl-2
family of proteins nor decreased expression levels of this
oncoprotein.1,2 These data suggest that the mechanism of
action of incednine is distinct from that of existing Bcl-xL
inhibitors. Further studies are necessary to determine the
biological target(s) of this compound.3
The intriguing biological properties of incednine define
it to be an important target for chemical synthesis and
further biological studies. While a total synthesis of in-
cednine has not yet been reported, syntheses of the aglycon
and of the disaccharide unit have been described.4 We
describe here our synthesis of the incednine disaccharide 2
in fully protected form.
Our strategy for the synthesis of disaccharide 2 is sum-
marized in Figure 1. We envisaged that the diamine pre-
cursor 3 could be obtained from a tandem azide reduction
and alcohol deoxygenation sequence carried out on thio-
carbonate 4. Intermediate4 originatesfrom disaccharide5,
which is the product of a β-selective glycosylation reaction
between the glycosyl donor 6 and acceptor 7.
(1) Futamura, Y.; Sawa, R.; Umezawa, Y.; Igarashi, M.; Nakamura,
H.; Hasegawa, K.; Yamasaki, M.; Tashiro, E.; Takahashi, Y.; Akamatsu,
Y.; Imoto, M. J. Am. Chem. Soc. 2008, 130, 1822.
(2) (a) Reed, J. C. Curr. Opin. Oncol. 1999, 11, 68. (b) Adams, J. M.;
Cory, S. Oncogene 2007, 26, 1324. (c) Wang, J.-L.; Liu, D.; Zhang, Z.-J.;
Shan, S.; Han, X.; Srinivasula, S. M.; Croce, C. M.; Alnemri, E. S.;
Huang, Z. Proc. Natl. Acad. Sci. U.S.A. 2000, 97, 7124. (d) Oltersdorf,
T.; Elmore, S. W.; Shoemaker, A. R.; Armstrong, R. C.; Augeri, D. J.;
Belli, B. A.; Bruncko, M.; Deckwerth, T. L.; Dinges, J.; Hajduk, P. J.;
Joseph, M. K.; Kitada, S.; Korsmeyer, S. J.; Kunzer, A. R.; Letai, A.; Li,
C.; Mitten, M. J.; Nettesheim, D. G.; Ng, S.; Nimmer, P. M.; O’Connor,
J. M.; Oleksijew, A.; Petros, A. M.; Reed, J. C.; Shen, W.; Tahir, S. K.;
Thompson, C. B.; Tomaselli, K. J.; Wang, B.; Wendt, M. D.; Zhang, H.;
Fesik, S. W.; Rosenberg, S. H. Nature 2005, 435, 677. (e) Shoemaker,
A. R.; Oleksijew, A.; Bauch, J.; Belli, B. A.; Borre, T.; Bruncko, M.;
Deckwirth, T.; Frost, D. J.; Jarvis, K.; Joseph, M. K.; Marsh, K.;
McClellan, W.; Nellans, H.; Ng, S.; Nimmer, P.; O’Connor, J. M.;
Oltersdorf, T.; Qing, W.; Shen, W.; Stavropoulos, J.; Tahir, S. K.; Wang,
B.; Warner, R.; Zhang, H.; Fesik, S. W.; Rosenberg, S. H.; Elmore, S. W.
Cancer Res. 2006, 66, 8731.
The synthesis of thioglycoside donor 6 originated from
the known azido sugar 9, which was prepared in nine steps
(23% overall yield) from commercially available allyl
R-D-galactopyranoside (8) according to a literature proce-
dure (Scheme 1).5 Removal of the 1,2-propylidene acetal
was accomplished by treatment of 9 with aqueous trifluoro-
acetic acid. Subsequent treatment of the crude diol with
acetic anhydride in pyridine provided diacetate 10 in
90% yield for the two steps. Conversion of 10 to the
(4) (a) Ohtani, T.; Tsukamoto, S.; Kanda, H.; Misawa, K.; Urakawa,
Y.; Fujimaki, T.; Imoto, M.; Takahashi, Y.; Takahashi, D.; Toshima, K.
Org. Lett. 2010, 12, 5068. (b) Ohtani, T.; Sakai, S.; Takada, A.;
Takahashi, D.; Toshima, K. Org. Lett. 2011, 13, 6126.
(3) Kobayashi, H.; Harada, H.; Nakamura, M.; Futamura, Y.; Ito,
A.; Yoshida, M.; Iemura, S.-i.; Shin-ya, K.; Doi, T.; Takahashi, T.;
Natsume, T.; Imoto, M.; Sakakibara, Y. BMC Chem. Biol. 2012, 12, 2.
€
(5) Tietze, L. F.; Bohnke, N.; Brasche, G. ARKIVOC 2007, 12.
r
10.1021/ol303093z
Published on Web 12/18/2012
2012 American Chemical Society